Open AccessWhat motivates or demotivates intravenous drug users to participate in hypothetical HIV vaccine efficacy trial? A qualitative study from urban Tanzania
Author(s) -
Masunga K. Iseselo,
Edith A. M. Tarimo,
Eric Sandström,
Asli Kulane
Publication year - 2020
Publication title -
east african health research journal
Language(s) - English
Resource type - Journals
eISSN - 2520-5285
pISSN - 2520-5277
DOI - 10.24248/eahrj.v4i2.636
Subject(s) - hiv vaccine , tanzania , medicine , qualitative research , focus group , vaccine trial , clinical trial , family medicine , vaccine efficacy , stigma (botany) , human immunodeficiency virus (hiv) , environmental health , vaccination , immunology , psychiatry , social science , environmental science , environmental planning , marketing , sociology , business
HIV vaccine efficacy trials require the active participation of volunteers who are committed and adherent to the study protocol. However, information about the influence of Injecting Drug Users (IDUs) to participate in HIV vaccine efficacy trials in low-income countries is inadequate. The present study explored the factors that motivate or hinder IDUs from participating in HIV vaccine efficacy trials in Dar es Salaam, Tanzania.